Therapeutic Modulation Of Peripheral Blood Cells And Inflammatory Indices During 52 Weeks Of Risankizumab In Responder Patients With Moderate-to-Severe Psoriasis: Results From A Multicenter Prospective Study
在接受利沙珠单抗治疗 52 周的中重度银屑病有效患者中，外周血细胞和炎症指标的治疗性调节：一项多中心前瞻性研究的结果
期刊:Dermatology Practical & Conceptual
影响因子:2.3
doi:10.5826/dpc.1504a5733
Di Cesare, Antonella; Rosi, Elia; Trovato, Emanuele; Pescitelli, Leonardo; Panduri, Salvatore; Margiotta, Flavia Manzo; Michelucci, Alessandra; Capalbo, Eugenio; Dragotto, Martina; Magnano, Michela; Rossari, Susanna; Savarese, Imma; Buggiani, Gionata; Milanesi, Nicola; Lorenzoni, Elisa; Ricceri, Federica; Romanelli, Marco; Rubegni, Pietro; Pimpinelli, Nicola; Prignano, Francesca
